Literature DB >> 29530581

A systematic approach to the formulation of anti-onychomycotic nail patches.

K Rizi1, I K Mohammed2, K Xu1, A J Kinloch2, M N Charalambides2, S Murdan3.   

Abstract

Nail patches have a potential role as drug carriers for the topical treatment of nail diseases such as onychomycosis, a common condition. Our aim was therefore to develop a systematic and novel approach to the formulation of a simple drug-in-adhesive ungual patch. Twelve pressure-sensitive adhesives (PSAs), four backing membranes, two release liners and three drugs were screened for pharmaceutical and mechanical properties. From this initial screening, two PSAs, two drugs, one backing membrane and one release liner were selected for further investigation. Patches were prepared by solvent-casting and characterised. The patches had good uniformity of thickness and of drug content, and showed minimal drug crystallisation during six months of storage. Meanwhile, the drug stability in the patch upon storage and patch adhesion to the nail was influenced by the nature of the drug, the PSA and the backing membrane. The reported methodology paves the way for a systematic formulation of ungual nail patches to add to the armamentarium of nail medicines. Further, from this work, the best patch formulation has been identified.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Nail; Onychomycosis; Patch; Peel tests; Pressure-sensitive adhesive; Tack; Work of adhesion

Mesh:

Substances:

Year:  2018        PMID: 29530581     DOI: 10.1016/j.ejpb.2018.02.032

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  What can GP data tell us about the treatment of onychomycosis in the UK?

Authors:  M Sajeed; L Wei; S Murdan
Journal:  Skin Health Dis       Date:  2021-12-16

2.  Printing Drugs onto Nails for Effective Treatment of Onychomycosis.

Authors:  Thomas D Pollard; Margherita Bonetti; Adam Day; Simon Gaisford; Mine Orlu; Abdul W Basit; Sudaxshina Murdan; Alvaro Goyanes
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.